Anticoagulant occur warfarin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Atrial Appendage

Organisms1

Diseases28

Thromboembolism Hemorrhage Atrial Fibrillation Thrombosis Venous Thrombosis Thrombophlebitis Venous Thromboembolism Antiphospholipid Syndrome Pulmonary Embolism Stroke Blood Coagulation Disorders Thrombophilia Embolism Intracranial Hemorrhages Hypoprothrombinemias Hematoma Activated Protein C Resistance Vitamin K Deficiency Protein S Deficiency Recurrence Antithrombin III Deficiency Cerebral Hemorrhage Protein C Deficiency Lupus Erythematosus, Systemic Postoperative Hemorrhage Disseminated Intravascular Coagulation Cerebrovascular Disorders Intracranial Embolism and Thrombosis

Chemicals and Drugs60

Warfarin Anticoagulants Vitamin K Epoxide Reductases Lupus Coagulation Inhibitor Rodenticides beta-Alanine Protein C 4-Hydroxycoumarins Acenocoumarol Vitamin K Heparin Antithrombins Phenindione Factor Xa Heparin, Low-Molecular-Weight Blood Coagulation Factors Prothrombin Mixed Function Oxygenases Protein S Thrombomodulin Aryl Hydrocarbon Hydroxylases Aspirin Thrombin Phenprocoumon Antibodies, Antiphospholipid Platelet Aggregation Inhibitors Benzimidazoles Fibrinolytic Agents Thiophenes Antithrombin III Antibodies, Anticardiolipin Vitamin K 1 Pyridones Factor X Coagulants Enoxaparin Dicumarol Thromboplastin Hirudins Heparin Antagonists Factor V beta 2-Glycoprotein I Factor VII Factor Va Pipecolic Acids Antithrombin Proteins Coumarins Fibrin Fibrinogen Degradation Products Dalteparin Azetidines Benzylamines Carbon-Carbon Ligases Morpholines Dermatan Sulfate Heparin Cofactor II Cardiolipins Factor VIIa Polysaccharides Ancrod Arthropod Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment22

Prothrombin Time Partial Thromboplastin Time Blood Coagulation Tests Thrombin Time International Normalized Ratio Administration, Oral Drug Monitoring Treatment Outcome Risk Factors Drug Dosage Calculations Heart Valve Prosthesis Retrospective Studies Prospective Studies Follow-Up Studies Drug Therapy, Combination Perioperative Care Whole Blood Coagulation Time Risk Assessment Oral Surgical Procedures Drug Administration Schedule Blood Specimen Collection Randomized Controlled Trials as Topic

Phenomena and Processes10

Prothrombin Time Blood Coagulation Partial Thromboplastin Time Thrombin Time Drug Interactions Hemostasis Dose-Response Relationship, Drug Time Factors Herb-Drug Interactions Whole Blood Coagulation Time

Disciplines and Occupations1

Pharmacogenetics

Health Care9

Rodent Control Treatment Outcome Risk Factors Retrospective Studies Prospective Studies Follow-Up Studies Perioperative Care Risk Assessment Randomized Controlled Trials as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Health Care

Warfarin Anticoagulants Vitamin K Epoxide Reductases Prothrombin Time Lupus Coagulation Inhibitor Blood Coagulation Thromboembolism Rodenticides Hemorrhage beta-Alanine Protein C 4-Hydroxycoumarins Partial Thromboplastin Time Acenocoumarol Vitamin K Atrial Fibrillation Heparin Antithrombins Phenindione Blood Coagulation Tests Factor Xa Thrombosis Heparin, Low-Molecular-Weight Blood Coagulation Factors Thrombin Time Prothrombin Mixed Function Oxygenases Protein S International Normalized Ratio Venous Thrombosis Thrombophlebitis Administration, Oral Thrombomodulin Aryl Hydrocarbon Hydroxylases Venous Thromboembolism Antiphospholipid Syndrome Aspirin Pulmonary Embolism Thrombin Pharmacogenetics Drug Monitoring Stroke Blood Coagulation Disorders Phenprocoumon Antibodies, Antiphospholipid Rodent Control Platelet Aggregation Inhibitors Benzimidazoles Thrombophilia Fibrinolytic Agents Thiophenes Antithrombin III Antibodies, Anticardiolipin Drug Interactions Vitamin K 1 Pyridones Factor X Embolism Coagulants Enoxaparin Dicumarol Thromboplastin Intracranial Hemorrhages Hemostasis Hirudins Treatment Outcome Heparin Antagonists Hypoprothrombinemias Factor V Dose-Response Relationship, Drug beta 2-Glycoprotein I Risk Factors Hematoma Factor VII Activated Protein C Resistance Factor Va Pipecolic Acids Time Factors Drug Dosage Calculations Herb-Drug Interactions Heart Valve Prosthesis Antithrombin Proteins Coumarins Retrospective Studies Vitamin K Deficiency Protein S Deficiency Fibrin Fibrinogen Degradation Products Recurrence Dalteparin Antithrombin III Deficiency Cerebral Hemorrhage Prospective Studies Azetidines Benzylamines Carbon-Carbon Ligases Morpholines Protein C Deficiency Follow-Up Studies Dermatan Sulfate Heparin Cofactor II

No FAQ available that match "anticoagulant occur warfarin"